Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities

AD Robinson, ML Eich, S Varambally - Cancer letters, 2020 - Elsevier
Cancer is a disease of uncontrolled cell growth and a major cause of death worldwide. Many
molecular events characterize tumor initiation and progression. Global gene expression …
被引用次数：65 相关文章

Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities

AD Robinson, ML Eich, S Varambally - Cancer Lett., 2020 - kups.ub.uni-koeln.de
Cancer is a disease of uncontrolled cell growth and a major cause of death worldwide. Many
molecular events characterize tumor initiation and progression. Global gene expression …

Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities

AD Robinson, ML Eich, S Varambally - Cancer letters, 2020 - pubmed.ncbi.nlm.nih.gov
Cancer is a disease of uncontrolled cell growth and a major cause of death worldwide. Many
molecular events characterize tumor initiation and progression. Global gene expression …

Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities.

AD Robinson, ML Eich, S Varambally - Cancer Letters, 2019 - europepmc.org
Cancer is a disease of uncontrolled cell growth and a major cause of death worldwide. Many
molecular events characterize tumor initiation and progression. Global gene expression …

Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities

AD Robinson, ML Eich, S Varambally - Cancer Lett., 2020 - kups.ub.uni-koeln.de
Cancer is a disease of uncontrolled cell growth and a major cause of death worldwide. Many
molecular events characterize tumor initiation and progression. Global gene expression …